Sandra Kurtin, PhD, ANP-C, AOCN, on The Burkitt Lymphoma International Prognostic Index

Sandra Kurtin, PhD, ANP-C, AOCN, of The University of Arizona Cancer Center, discusses what advanced practitioners need to know about a novel prognostic index specific to Burkitt lymphoma. The index can identify patients for whom treatment may be de-escalated, as well as patients for whom currently available immunochemotherapy is appropriate (Abstract 705).